In addition, p22phox was found to be overexpressed in NPC cells, including in malignant cells lacking LMP1 expression, which suggests that p22phox could be an effective target for the NOX inhibitor diphenyleneiodonium (DPI). Here, PDLIM7 is linked to nasopharyngeal carcinoma.